Rafael Holdings, Inc. Class B Common Stock (NY:RFL)

1.240 +0.010 (+0.81%)

Official Closing Price Updated: 7:00 PM EST, Nov 19, 2025 Add to My Watchlist

Price and Volume

Volume	37,558
Open	1.270
Bid (Size)	1.150 (100)
Ask (Size)	1.300 (300)
Prev. Close	1.230
Today's Range	1.190 - 1.280
52wk Range	1.190 - 3.190
Shares Outstanding	100
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

October 29, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Performance

YTD	-28.6%	-28.6%
1 Month	-10.8%	-10.8%
3 Month	-15.1%	-15.1%
6 Month	-7.5%	-7.5%
1 Year	-34.2%	-34.2%

More News

Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors

October 28, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 22, 2025

Via Benzinga

Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old

September 16, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)

August 27, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 18, 2025

Via Benzinga

Which stocks are gapping on Wednesday? ↗

June 18, 2025

Via Chartmill

Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

June 18, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

Unusual volume stocks are being observed in Thursday's session. ↗

June 12, 2025

Via Chartmill

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

June 11, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 11, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-06-11: top gainers and losers in today's session. ↗

June 11, 2025

Via Chartmill

Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

June 11, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 10, 2025

Via Benzinga

Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

June 04, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 30, 2025

Via Benzinga

Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of

May 20, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 05, 2025

Via Benzinga

Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

May 05, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

April 29, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role

April 24, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

March 26, 2025

From Rafael Holdings, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Rafael Holdings, Inc. Class B Common Stock publicly traded?

Yes, Rafael Holdings, Inc. Class B Common Stock is publicly traded.

What exchange does Rafael Holdings, Inc. Class B Common Stock trade on?

Rafael Holdings, Inc. Class B Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Rafael Holdings, Inc. Class B Common Stock?

The ticker symbol for Rafael Holdings, Inc. Class B Common Stock is RFL on the New York Stock Exchange

What is the current price of Rafael Holdings, Inc. Class B Common Stock?

The current price of Rafael Holdings, Inc. Class B Common Stock is 1.240

When was Rafael Holdings, Inc. Class B Common Stock last traded?

The last trade of Rafael Holdings, Inc. Class B Common Stock was at 11/19/25 07:00 PM ET

What is the market capitalization of Rafael Holdings, Inc. Class B Common Stock?

The market capitalization of Rafael Holdings, Inc. Class B Common Stock is 124.00

How many shares of Rafael Holdings, Inc. Class B Common Stock are outstanding?

Rafael Holdings, Inc. Class B Common Stock has 124 shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.